Jeff Garro
Stock Analyst at Stephens & Co.
(0.55)
# 3,799
Out of 4,711 analysts
46
Total ratings
20.59%
Success rate
-17.72%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $4.18 | +19.62% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $57.83 | -4.89% | 1 | Dec 20, 2024 | |
| VEEV Veeva Systems | Initiates: Overweight | n/a | $224.15 | - | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $4.91 | +12.02% | 3 | Dec 20, 2024 | |
| IQV IQVIA Holdings | Initiates: Overweight | $250 | $197.27 | +26.73% | 2 | Dec 20, 2024 | |
| HNRG Hallador Energy Company | Initiates: Buy | $17 | $10.93 | +55.54% | 1 | Dec 9, 2024 | |
| TBRG TruBridge | Maintains: Equal-Weight | $13 → $17 | $18.19 | -6.54% | 1 | Nov 20, 2024 | |
| SLP Simulations Plus | Initiates: Overweight | $39 | $28.58 | +36.46% | 1 | Nov 15, 2024 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $9 | $7.09 | +26.94% | 2 | Nov 14, 2024 | |
| EVH Evolent Health | Downgrades: Equal-Weight | $16 | $11.41 | +40.23% | 4 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $8 | $3.48 | +129.89% | 6 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $25.16 | +11.29% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $10.71 | +86.74% | 4 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $9.44 | +196.61% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $33 | $20.07 | +64.42% | 1 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $10.61 | +88.50% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $4.19 | -6.92% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $3.03 | -0.99% | 3 | May 6, 2022 |
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $4.18
Upside: +19.62%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $57.83
Upside: -4.89%
Veeva Systems
Dec 20, 2024
Initiates: Overweight
Price Target: n/a
Current: $224.15
Upside: -
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $4.91
Upside: +12.02%
IQVIA Holdings
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $197.27
Upside: +26.73%
Hallador Energy Company
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $10.93
Upside: +55.54%
TruBridge
Nov 20, 2024
Maintains: Equal-Weight
Price Target: $13 → $17
Current: $18.19
Upside: -6.54%
Simulations Plus
Nov 15, 2024
Initiates: Overweight
Price Target: $39
Current: $28.58
Upside: +36.46%
Health Catalyst
Nov 14, 2024
Maintains: Equal-Weight
Price Target: $7 → $9
Current: $7.09
Upside: +26.94%
Evolent Health
Nov 8, 2024
Downgrades: Equal-Weight
Price Target: $16
Current: $11.41
Upside: +40.23%
Oct 9, 2024
Maintains: Overweight
Price Target: $10 → $8
Current: $3.48
Upside: +129.89%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $25.16
Upside: +11.29%
Oct 11, 2023
Reiterates: Overweight
Price Target: $20
Current: $10.71
Upside: +86.74%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $9.44
Upside: +196.61%
Apr 12, 2023
Initiates: Overweight
Price Target: $33
Current: $20.07
Upside: +64.42%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $10.61
Upside: +88.50%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $4.19
Upside: -6.92%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $3.03
Upside: -0.99%